Skip to main content
. Author manuscript; available in PMC: 2023 Jul 25.
Published in final edited form as: Med Res Arch. 2023 Jun 26;11(6):3784. doi: 10.18103/mra.v11i6.3784

Table 2.

Inflammatory bowel disease maintenance therapies during pregnancy and lactation[187,196,200]

Laboratory Values Endoscopy Radiology imaging Surgery Medication
Standard IBD laboratory values chacked Perform for strong indications: MRI and CT have similar diagnostics accuracy for assessing IBD Surgery intervention may be needed: Mange similar to nonpregnant IBD Patients
  • Trends for CRP and ESR may be helpful Posibly elevared

-Determining IBD disease activity Gadolinium should be avoided in pregnancy - Acute refractory colitis
- Perforation
Exceptions:
-Thiopurine-naïve patients avoid first start in pregnancy due to concerns for distinctive rare adverse reactions
  • Fecal calprotectin

-When results will change management The cumulative radiation exposure of a single CT scan (about 50 mGy) is below the level of concern -Abscess
-Severe hemorrhage
Methotrexate
contraindicated
  • Serum drug concentration

Flexible sigmoidoscopy is preferred oner pancolonoscopy when possible; can be performed unsedated, and in any trimester Ultrasound, where available is appropriate for terminal ileal disease -Bowel obstruction Tofacitinib: avoid due to limited human data
  • Posibly elevared
    • ESR
    • CRP
  • Alkaline phosphatase (elevated in lactation)

  • Reduced in pregnancy
    • Hemoglobin
    • Albumin

Abbreviation: Anti-TNFα, tumor-necrosis factor-α